parthenolide has been researched along with Cancer of Colon in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Chen, Y; Ding, Y; Ge, W; Guo, H; Li, S; Wang, M; Zhang, Q | 1 |
Kim, SL; Kim, SW; Lee, ST; Park, YR | 1 |
Bosia, A; Doublier, S; Ghigo, D; Miraglia, E; Pescarmona, G; Riganti, C; Viarisio, D | 1 |
Pajak, B | 1 |
1 review(s) available for parthenolide and Cancer of Colon
Article | Year |
---|---|
Antiapoptotic proteins as targets for bioactive compounds.
Topics: Butyrates; Colonic Neoplasms; Fatty Acids; Humans; Immunotherapy; Phytotherapy; Sesquiterpenes; Tanacetum parthenium | 2007 |
3 other study(ies) available for parthenolide and Cancer of Colon
Article | Year |
---|---|
Copper(I) oxide nanoparticles catalyzed click chemistry based synthesis of melampomagnolide B-triazole conjugates and their anti-cancer activities.
Topics: Antineoplastic Agents; Apoptosis; Catalysis; Cell Proliferation; Click Chemistry; Colonic Neoplasms; Copper; Drug Screening Assays, Antitumor; HCT116 Cells; Humans; Nanoparticles; Oxides; Sesquiterpenes; Triazoles | 2018 |
Parthenolide suppresses hypoxia-inducible factor-1α signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer.
Topics: Animals; Cell Hypoxia; Colonic Neoplasms; Down-Regulation; Epithelial-Mesenchymal Transition; Female; HCT116 Cells; HT29 Cells; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Pathologic; NF-kappa B; Sesquiterpenes; Signal Transduction; Xenograft Model Antitumor Assays | 2017 |
Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression.
Topics: Antimalarials; Antimetabolites, Antineoplastic; Artemisinins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Line, Tumor; Colonic Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Phosphorylation; Protein Transport; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sesquiterpenes | 2009 |